Valuation (91%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 3.36 | N/A |
| PEG Ratio (TTM) | 0.02 | N/A |
| P/S Ratio (TTM) | 12.77 | N/A |
| P/B Ratio (TTM) | 1.22 | N/A |
| P/FCF Ratio (TTM) | 19.78 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.27 | N/A |
| Price to 5YR AVG FCF Ratio | 18.75 | N/A |
Profitability (80%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 29.53% | N/A |
| ROE (TTM) | 35.17% | N/A |
| Net Profit Margin (TTM) | 379.52% | N/A |
| ROIC 5YR AVG | 6.73% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 36.77% | 143.39% | 81.19% |
| Revenue | 84.18% | 146.96% | 87.09% |
| Net Income | 36.98% | 144.45% | 81.81% |
| Cash Flow | 46.26% | 22.68% | 17.60% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.07 | N/A |
| Quick Ratio (TTM) | 0.07 | N/A |
| D/E Ratio (TTM) | 0.23 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 4.68 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 1.10% | N/A |